𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amino acid signaling through the mammalian target of rapamycin (mTOR) pathway: Role of glutamine and of cell shrinkage

✍ Scribed by Claudia Fumarola; Silvia La Monica; Guido G. Guidotti


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
357 KB
Volume
204
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Mammalian target of rapamycin (mTOR) mediates a signaling pathway that couples amino acid availability to S6 kinase (S6K) activation, translational initiation and cell growth rate, participating to a versatile checkpoint that inspects the energy status of the cell. The pathway is activated by branched‐chain amino acids (BCAA), leucine being the most effective, whereas amino acid dearth and ATP shortage lead to its deactivation. Glutamine‐ or amino acid‐deprivation and hyperosmotic stress induce a fast cell shrinkage (with marked decrease of the intracellular water volume) associated to mTOR‐dependent S6K1 dephosphorylation. Using cultured Jurkat cells, we have measured the changes of cell content and intracellular concentration of ATP, of relevant amino acids (BCAA) and of ninhydrin‐positive substances (NPS, as measure of NH~2~‐bearing organic osmolytes) under conditions that deactivate (leucine‐deprivation, glutamine‐deprivation, amino acid withdrawal, sorbitol‐induced hyperosmotic stress) or reactivate a previously deactivated, mTOR‐S6K1 pathway. We have also assessed the mitochondrial function by measurements of mitochondrial transmembrane potential in cells subjected to hypertonic stress. Our results indicate that diverse control signals converge on the mTOR‐S6K1 signaling pathway. In the presence of adequate energy resources, the pathway senses the amino acid availability as inward transport of effective amino acids (as BCAA and especially leucine), but its activation occurs only in the presence of an extracellular amino acid complement, with glutamine as obligatory component, and does not tolerate decrements of cell water volume incapable of maintaining adequate intracellular physicochemical conditions. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Curcumin inhibits the mammalian target o
✍ Christopher S. Beevers; Fengjun Li; Lei Liu; Shile Huang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 546 KB

## Abstract Curcumin (diferuloylmethane), a polyphenol natural product of the plant __Curcuma longa__, is undergoing early clinical trials as a novel anticancer agent. However, the anticancer mechanism of curcumin remains to be elucidated. Here we show that curcumin inhibited growth of rhabdomyosar

The mammalian target of rapamycin pathwa
✍ Jun Lian; Xiang-Hua Yan; Jian Peng; Si-Wen Jiang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 925 KB

## Abstract Mammalian target of rapamycin (mTOR) is a protein serine‐threonine kinase that functions as a central element in signaling pathway involved in control of cell growth and proliferation. mTOR exists in at least two distinct multi‐protein complexes, mTORC1 and mTORC2. mTOR kinase controls